Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry
- 17 February 2017
- journal article
- research article
- Published by Springer Nature in International Journal of Obesity
- Vol. 41 (8) , 1164-1168
Abstract
Background: The ‘obesity paradox’ refers to the fact that obese patients have better outcomes than normal weight patients. This has been observed in multiple cardiovascular conditions, but evidence for obesity paradox in pulmonary hypertension (PH) remains sparse. Methods: We categorized 267 patients from the National Institute of Health-PH registry into five groups based on body mass index (BMI): underweight, normal weight, overweight, obese and morbidly obese. Mortality was compared in BMI groups using the χ2 statistic. Five-year probability of death using the PH connection (PHC) risk equation was calculated, and the model was compared with BMI groups using Cox proportional hazards regression and Kaplan–Meier (KM) survival curves. Results: Patients had a median age of 39 years (interquartile range 30–50 years), a median BMI of 23.4 kg m−2 (21.0–26.8 kg m−2) and an overall mortality at 5 years of 50.2%. We found a U-shaped relationship between survival and 1-year mortality with the best 1-year survival in overweight patients. KM curves showed the best survival in the overweight, followed by obese and morbidly obese patients, and the worst survival in normal weight and underweight patients (log-rank P=0.0008). In a Cox proportional hazards analysis, increasing BMI was a highly significant predictor of improved survival even after adjustment for the PHC risk equation with a hazard ratio for death of 0.921 per kg m−2 (95% confidence interval: 0.886–0.954) (P<0.0001). Conclusion: We observed that the best survival was in the overweight patients, making this more of an ‘overweight paradox’ than an ‘obesity paradox’. This has implications for risk stratification and prognosis in group 1 PH patients.Keywords
This publication has 54 references indexed in Scilit:
- Frailty and Health-Related Quality of Life Among Residents of Long-Term Care FacilitiesJournal of Aging and Health, 2013
- Severe Pulmonary Hypertension: The Role of Metabolic and Endocrine DisordersPulmonary Circulation, 2012
- The obesity paradox in chronic disease: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2012
- Body Composition and Coronary Heart Disease Mortality—An Obesity or a Lean Paradox?Mayo Clinic Proceedings, 2011
- Comparison of Body Habitus in Patients With Pulmonary Arterial Hypertension Enrolled in the Registry to Evaluate Early and Long-term PAH Disease Management With Normative Values From the National Health and Nutrition Examination SurveyMayo Clinic Proceedings, 2011
- Chronic intermittent hypoxia caused by obstructive sleep apnea may play an important role in explaining the morbidity-mortality paradox of obesityMedical Hypotheses, 2011
- Body-Mass Index and Mortality among 1.46 Million White AdultsNew England Journal of Medicine, 2010
- Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analysesEuropean Heart Journal, 2010
- Predicting the 30-Year Risk of Cardiovascular DiseaseCirculation, 2009
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Circulation, 1983